![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1422, 2004-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anastrozole of global value in early breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 445, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anastrozole: first-line therapy for advanced breast cancer?
Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Perioperative chemotherapy beneficial in early breast cancer?
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tamoxifen plus chemotherapy worth it in early breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tamoxifen plus chemotherapy worth it in early breast cancer?
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :